Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Hai‐Jie Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2871-290X; OpenAlex author ID A5103915308. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
25
Papers, trials and grants by year

2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 8

  1. Toward Timely Diagnosis of Pancreatic Cancer: Revolutionizing Early Detection Through Genomics, Artificial Intelligence, and Noninvasive Biomarkers. Last author DOI 10.1111/jgh.70281↗
  2. Comparison of the upfront surgery and neoadjuvant therapy in resectable and borderline resectable pancreatic cancer: an updated systematic review and meta-anal… Last author DOI 10.1007/s13304-023-01626-0↗
  3. DNA damage repair mutations in pancreatic cancer- prognostic or predictive? First author DOI 10.3389/fonc.2023.1267577↗
  4. Comment on "Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Mu… Co-author DOI 10.1097/sla.0000000000004283↗
  5. Association of Germline Variants in Human DNA Damage Repair Genes and Response to Adjuvant Chemotherapy in Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.jamcollsurg.2020.06.019↗
  6. Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment. Co-author DOI 10.21037/atm.2019.10.91↗
  7. Optimized modification of the eighth edition of AJCC TNM staging system for resected pancreatic ductal adenocarcinoma. Co-author DOI 10.2217/fon-2019-0264↗
  8. Predictors of Resectability and Survival in Patients with Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment with FOLFIRINOX. Co-author DOI 10.1097/sla.0000000000002842↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fu‐Yu Li · 5 shared papers, 2018–2026 · strength 1.25
  2. Jun Yu · 3 shared papers, 2019–2023 · strength 0.42
  3. Hussain Ma · 1 shared paper, 2026 · strength 0.36
  4. Ning Pu · 3 shared papers, 2019–2020 · strength 0.29
  5. Yayun Zhu · 3 shared papers, 2019–2020 · strength 0.29
  6. Siqi Yang · 1 shared paper, 2024 · strength 0.28
  7. Nan-Sheng Cheng · 1 shared paper, 2021 · strength 0.22
  8. Tian‐Run Lv · 1 shared paper, 2023 · strength 0.22
  9. Ya-Fei Hu · 1 shared paper, 2023 · strength 0.22
  10. Heng‐Chung Kung · 1 shared paper, 2023 · strength 0.22
  11. Lingdi Yin · 2 shared papers, 2019 · strength 0.18
  12. Shanshan Gao · 2 shared papers, 2019 · strength 0.18
  13. Jin Peng He · 1 shared paper, 2020 · strength 0.11
  14. Richard A. Burkhart · 1 shared paper, 2020 · strength 0.11
  15. William R. Burns · 1 shared paper, 2020 · strength 0.11
  16. Lei Zheng · 1 shared paper, 2020 · strength 0.11
  17. Michael Goggins · 1 shared paper, 2020 · strength 0.11
  18. Daniel A. Laheru · 1 shared paper, 2020 · strength 0.11
  19. Joseph R. Habib · 1 shared paper, 2019 · strength 0.10
  20. Wenhui Lou · 1 shared paper, 2019 · strength 0.10
  21. Shimpei Maeda · 1 shared paper, 2019 · strength 0.08
  22. Qiangda Chen · 1 shared paper, 2019 · strength 0.08
  23. Wenhui Lou · 1 shared paper, 2019 · strength 0.08
  24. Yong Wu · 1 shared paper, 2019 · strength 0.08
  25. Wenchuan Wu · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.